ATE556134T1 - Mesenchymstammzellen und verwendungendafür - Google Patents

Mesenchymstammzellen und verwendungendafür

Info

Publication number
ATE556134T1
ATE556134T1 AT05725577T AT05725577T ATE556134T1 AT E556134 T1 ATE556134 T1 AT E556134T1 AT 05725577 T AT05725577 T AT 05725577T AT 05725577 T AT05725577 T AT 05725577T AT E556134 T1 ATE556134 T1 AT E556134T1
Authority
AT
Austria
Prior art keywords
stem cells
methods
animal
mesenchymal stem
mesenchyma stem
Prior art date
Application number
AT05725577T
Other languages
English (en)
Inventor
Mark Pittenger
Sudeepta Aggarwal
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Priority claimed from PCT/US2005/008506 external-priority patent/WO2005093044A1/en
Application granted granted Critical
Publication of ATE556134T1 publication Critical patent/ATE556134T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05725577T 2004-03-22 2005-03-15 Mesenchymstammzellen und verwendungendafür ATE556134T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55511804P 2004-03-22 2004-03-22
PCT/US2005/008506 WO2005093044A1 (en) 2004-03-22 2005-03-15 Mesenchymal stem cells and uses therefor

Publications (1)

Publication Number Publication Date
ATE556134T1 true ATE556134T1 (de) 2012-05-15

Family

ID=46060822

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05725577T ATE556134T1 (de) 2004-03-22 2005-03-15 Mesenchymstammzellen und verwendungendafür

Country Status (5)

Country Link
JP (8) JP6114500B2 (de)
AT (1) ATE556134T1 (de)
CA (3) CA2868733C (de)
ES (7) ES2708627T3 (de)
TR (1) TR201901268T4 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2708627T3 (es) * 2004-03-22 2019-04-10 Mesoblast Int Sarl Células madre mesenquimales y sus usos
EP2298863B1 (de) * 2004-03-22 2015-07-22 Mesoblast International Sàrl Mesenchymale Stammzellen und deren Verwendungen
WO2014098960A2 (en) * 2012-05-16 2014-06-26 The Johns Hopkins University Stem cells as an individualized maternal therapy for prevention of prematurity
JP2016210730A (ja) * 2015-05-08 2016-12-15 上田　実 医薬組成物及びその製造方法並びに医薬品
CN109952371A (zh) 2016-11-15 2019-06-28 株式会社钟化 包含来自胎儿附属物的间充质系干细胞的细胞群、其制备方法、以及医药组合物
AU2018372631B2 (en) 2017-11-22 2025-06-05 Mesoblast International Sarl Cellular compositions and methods of treatment I
WO2019132026A1 (ja) 2017-12-28 2019-07-04 株式会社カネカ 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
WO2020251020A1 (ja) 2019-06-14 2020-12-17 株式会社カネカ 間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法
WO2021028583A1 (en) * 2019-08-15 2021-02-18 Nextcell Pharma Ab Allogeneic composition for treatment of cns disorders
CN113813288B (zh) * 2021-08-11 2024-02-13 谢岩 间充质干细胞及包含其的组合物用于制备治疗烧伤难愈创面的药物的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651641B2 (ja) * 1983-08-29 1994-07-06 株式会社ミドリ十字 ガンマ・インターフェロン組成物
JPH01501792A (ja) * 1986-03-17 1989-06-22 シェリング・コーポレーション γ型インターフェロンによる癌の治療
EP0784482A2 (de) * 1994-06-07 1997-07-23 The Regents Of The University Of Minnesota Methode zur inhibition der antigen spezifischen t-zellen immunantwort
CA2253724A1 (en) * 1996-04-26 1997-11-06 Case Western Reserve University Skin regeneration using mesenchymal stem cells
ES2258329T3 (es) * 1998-03-18 2006-08-16 Osiris Therapeutics, Inc. Celulas madre mesenquimaticas para la prevencion y tratamiento de respuestas inmunes en trasplantes.
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
ES2205792T3 (es) 1998-04-03 2004-05-01 Osiris Therapeutics, Inc. Celulas madre mesenquimatosas como inmunosupresores.
CN1307303C (zh) * 2000-01-19 2007-03-28 帕卡什·S·吉尔 针对反义vegf寡核苷酸的方法和组合物
ES2353061T5 (es) * 2000-04-25 2014-04-07 Osiris Therapeutics, Inc. Reparación de articulaciones utilizando células madre mesenquimatosas
MXPA04007426A (es) * 2002-02-01 2004-10-11 Schering Corp Usos de citosina de mamifero; reactivos relacionados.
JP3897343B2 (ja) * 2002-08-01 2007-03-22 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
CA2547899C (en) * 2002-12-05 2014-04-15 Case Western Reserve University Cell-based therapies for ischemia
ES2708627T3 (es) * 2004-03-22 2019-04-10 Mesoblast Int Sarl Células madre mesenquimales y sus usos
EP2298863B1 (de) * 2004-03-22 2015-07-22 Mesoblast International Sàrl Mesenchymale Stammzellen und deren Verwendungen

Also Published As

Publication number Publication date
CA2934682C (en) 2021-12-07
JP6382360B2 (ja) 2018-08-29
JP5997237B2 (ja) 2016-09-28
JP7033159B2 (ja) 2022-03-09
ES2643030T3 (es) 2017-11-21
JP2015061862A (ja) 2015-04-02
CA2868733C (en) 2019-12-17
JP2020111591A (ja) 2020-07-27
ES2544689T3 (es) 2015-09-02
HK1205531A1 (en) 2015-12-18
ES2385450T3 (es) 2012-07-25
ES2708627T3 (es) 2019-04-10
ES2643076T3 (es) 2017-11-21
JP2019014747A (ja) 2019-01-31
JP6114500B2 (ja) 2017-04-12
TR201901268T4 (tr) 2019-02-21
ES2657382T5 (es) 2021-07-12
JP7546239B2 (ja) 2024-09-06
ES2645018T3 (es) 2017-12-01
CA3135582A1 (en) 2005-10-06
JP2012176948A (ja) 2012-09-13
JP6757300B2 (ja) 2020-09-16
HK1205677A1 (en) 2015-12-24
JP2023065486A (ja) 2023-05-12
ES2657382T3 (es) 2018-03-05
CA2934682A1 (en) 2005-10-06
JP2021191771A (ja) 2021-12-16
CA2868733A1 (en) 2005-10-06
JP6757383B2 (ja) 2020-09-16
JP2017080507A (ja) 2017-05-18
JP2018009002A (ja) 2018-01-18

Similar Documents

Publication Publication Date Title
EP2298863A3 (de) Mesenchymale Stammzellen und deren Verwendungen
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
EP4438721A3 (de) Mesenchymale stammzellen und verwendungen davon
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
AR061171A1 (es) Proteinas de union al factor de crecimiento de hepatocitos (fch)
EA200971053A1 (ru) Способы лечения кожных язв
MX2007004551A (es) Compuestos tiadiazol y metodos de uso.
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
EA200870019A1 (ru) Лактамовые соединения и способы их применения
NZ606825A (en) Methods and compositions for treating complement-associated disorders
EA201301078A1 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
TW200732347A (en) VEGF analogs and methods of use
NO20092637L (no) Fremgangsmater for behandling
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
DOP2013000105A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
CY1118073T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης
TW200738657A (en) Thiazole compounds and methods of use
ECSP12012211A (es) Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf)
GT200500260A (es) Amidas biciclicas como inhibidores de cinasa.
EA200870254A1 (ru) Способ лечения воспалительных заболеваний
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
EA200970110A1 (ru) Производные 6,9-дизамещённого пурина и их применение для лечения кожи
MX2010009623A (es) Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
MX2010009625A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
EA200600921A1 (ru) Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний